Arca Biopharma Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

Arca Biopharma General Information

Description

Operator of a clinical-stage biopharmaceutical company focused on developing therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

Contact Information

Website
www.arcabio.com
Formerly Known As
Hyseq
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 10170 Church Ranch Way
  • Suite 100
  • Westminster, CO 80021
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Oruka Therapeutics
Vertical(s)
Corporate Office
  • 10170 Church Ranch Way
  • Suite 100
  • Westminster, CO 80021
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arca Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 29-Aug-2024 Completed Generating Revenue
12. 2PO 02-Apr-2021 Cancelled Generating Revenue
11. PIPE 03-Jun-2020 Completed Generating Revenue
10. Secondary Transaction - Open Market Completed Generating Revenue
9. PIPE 15-Jun-2015 Completed Clinical Trials - Phase 2
8. PIPE 20-Feb-2014 Completed Generating Revenue
7. PIPE 17-Jun-2013 Completed Generating Revenue
6. PIPE 18-Apr-2011 Completed Generating Revenue
5. Grant 04-Nov-2010 $489K $33.2M Completed Generating Revenue
4. Reverse Merger 28-Jan-2009 $33.2M Completed Startup
To view Arca Biopharma’s complete valuation and funding history, request access »

Arca Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biopharmaceutical company focused on developing therapies for cardiovascular diseases. The
Drug Discovery
Westminster, CO
5 As of 2023

Pittsburgh, PA
 

Foster City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arca Biopharma Competitors (11)

One of Arca Biopharma’s 11 competitors is CytoAgents, a Venture Capital-Backed company based in Pittsburgh, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytoAgents Venture Capital-Backed Pittsburgh, PA
Gilead Formerly VC-backed Foster City, CA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
CyTuVax Venture Capital-Backed Maastricht, Netherlands
Merck & Co. Corporation Rahway, NJ
You’re viewing 5 of 11 competitors. Get the full list »

Arca Biopharma Patents

Arca Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3101700-A1 Methods and compositions involving bucindolol for the treatment of atrial fibrillation Pending 25-May-2018
EP-3691635-A2 Methods and compositions involving bucindolol for the treatment of atrial fibrillation Active 25-May-2018
EP-3691635-A4 Methods and compositions involving bucindolol for the treatment of atrial fibrillation Active 25-May-2018
EP-3691635-B1 Methods and compositions involving bucindolol for the treatment of atrial fibrillation Active 25-May-2018
EP-4275684-A1 Methods and compositions involving bucindolol for the treatment of atrial fibrillation Pending 25-May-2018 A61K31/4045
To view Arca Biopharma’s complete patent history, request access »

Arca Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arca Biopharma Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
Boulder Ventures Venture Capital Minority
InterWest Partners Venture Capital Minority
New Enterprise Associates Venture Capital Minority
New Leaf Venture Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Arca Biopharma Investments & Acquisitions (3)

Arca Biopharma’s most recent deal was a Reverse Merger with Oruka Therapeutics for . The deal was made on 29-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oruka Therapeutics 29-Aug-2024 Reverse Merger Biotechnology
Nuvelo 27-Jan-2009 Merger/Acquisition Drug Discovery
Viridian Therapeutics 05-Feb-2008 Seed Round Drug Discovery
To view Arca Biopharma’s complete investments and acquisitions history, request access »

Arca Biopharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Arca Biopharma’s complete esg history, request access »

Arca Biopharma FAQs

  • When was Arca Biopharma founded?

    Arca Biopharma was founded in 1992.

  • Where is Arca Biopharma headquartered?

    Arca Biopharma is headquartered in Westminster, CO.

  • What is the size of Arca Biopharma?

    Arca Biopharma has 5 total employees.

  • What industry is Arca Biopharma in?

    Arca Biopharma’s primary industry is Drug Discovery.

  • Is Arca Biopharma a private or public company?

    Arca Biopharma is a Private company.

  • What is Arca Biopharma’s current revenue?

    The current revenue for Arca Biopharma is .

  • How much funding has Arca Biopharma raised over time?

    Arca Biopharma has raised $100M.

  • Who are Arca Biopharma’s investors?

    Atlas Venture, Boulder Ventures, InterWest Partners, New Enterprise Associates, and New Leaf Venture are 5 of 15 investors who have invested in Arca Biopharma.

  • Who are Arca Biopharma’s competitors?

    CytoAgents, Gilead, Ability Pharma, CyTuVax, and Merck & Co. are some of the 11 competitors of Arca Biopharma.

  • When was Arca Biopharma acquired?

    Arca Biopharma was acquired on 29-Aug-2024.

  • Who acquired Arca Biopharma?

    Arca Biopharma was acquired by Oruka Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process